General practitioner · Willebroek · BE · Founded 2021 · Accounts through 2025 · Updated Jul 27, 2026
No public value estimate is available for this company yet. Review the registered details, express interest or claim the profile as the owner.
Is this your company? Claim and manage this profile
DR. OVERBERGH CAROLIEN has public filings, but the EBITDA/revenue relationship looks proxy-based or incomplete. Upswitch withholds the public range until clean turnover and normalised EBITDA are verified.
Create a free account to add verified turnover, normalised EBITDA, debt and one-offs for DR. OVERBERGH CAROLIEN in a private workspace.
We keep this public page conservative, so weak filings never become a false price.The page can still show filed facts, but the automatic public range is blocked when those facts would make the multiple misleading.
DR. OVERBERGH CAROLIEN, a general practitioner, is registered at an address in Willebroek, Belgium. The company was founded in 2021, incorporated as a Besloten Vennootschap.
DR. OVERBERGH CAROLIEN is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0773685856 and VAT number BE0773685856. This profile consolidates KBO registry, official annual accounts into one indexable company dossier.
Within the Belgian NACE 86.21 cluster, public-record data is filed annually via the national company registry.
Across the 2024-2025 window the gross-margin line has stayed broadly flat, moving from €179,065 to €193,748. EBITDA for 2025 comes in at €192,145. Because this line is gross margin from an abbreviated filing, not reported turnover, it is treated as public context rather than an automatic valuation base.
The most recent annual filing covers 2025 (period end 2025-12-31).
The data on this page is a public, point-in-time view of DR. OVERBERGH CAROLIEN's regulator-filed footprint, built to support sellability context and acquisition research without overstating the public valuation evidence.
Register your interest privately. Upswitch reviews every request and keeps it queued until a safe, verified owner contact route is available.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Claim this companyPublic regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €193,748 | €192,145 | €390,875 | €131,193 | - |
| 202431 Dec 2024 | €179,065 | €177,502 | €489,196 | €223,547 | - |
DR. OVERBERGH CAROLIEN was founded in 2021 and is registered with Belgian Crossroads Bank for Enterprises (KBO), incorporated as a Besloten Vennootschap.
DR. OVERBERGH CAROLIEN is registered under NACE 86.21. That places the business within the Belgian cluster for this activity.
According to the company registry, DR. OVERBERGH CAROLIEN is based in Willebroek, BE.
The most recently filed annual accounts cover fiscal year 2025 (period end 2025-12-31), publicly available via Belgian Crossroads Bank for Enterprises (KBO).
This page shows official or licensed public company facts and valuation-readiness context for DR. OVERBERGH CAROLIEN; it does not show an automated public valuation range. The available facts may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
Indicative public valuation range based on financial year 2025. This historical record does not yet contain an immutable calculation snapshot, so no sector range is reconstructed after the fact. Not a transaction value, asking price or fairness opinion.
